Advanced search×

Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings.

M M Bagnasco, G G Mariani, G G Passalacqua, C C Motta, M M Bartolomei, P P Falagiani, G G Mistrello, and G W GW Canonica

J Allergy Clin Immunol 100(1):122-9 (1997) PMID 9257796

The clinical effectiveness of noninjectable routes for specific immunotherapy has been demonstrated in many studies, but no data are available on the kinetics of allergens administered by these routes. Therefore we studied the kinetics of the radiolabeled purified major Parietaria judaica allergen (Par j 1) after sublingual, oral, and intranasal administration to healthy human beings.

Version: za2963e q8za4 q8zbd q8zc4 q8zdb q8ze5 q8zfb q8zg7

Similar articles you may find interesting…

  1. "Fertile" intestine nuclei.
    J B JB Gurdon and V V Uehlinger

    Nature 210(5042):1240-1 (1966) PMID 5967799

  2. Population robustness arising from cellular heterogeneity.
    Pawel P Paszek, Sheila S Ryan, ... Michael R H MR White

    Proc Natl Acad Sci U S A 107(25):11644-9 (2010) PMID 20534546

    We show that in the NF-kappaB signaling system, the precise timing of a dual-delayed negative feedback motif [involving stochastic transcription of inhibitor kappaB (IkappaB)-alpha and -epsilon] is optimized to induce heterogeneous timing of NF-kappaB oscillations between individual cells. We sugges...